Growth rate-corrected (GR) dose-response metric signatures across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 3 of 4: Median, upper quartile, and lower quartile GR metrics per perturbagen. - Dataset (ID:20270)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
| HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
|---|---|---|---|---|---|
| 10107-5 | MG-132 | LSM-1107 |  | 462382 | |
| 10107-2 | MG-132 | LSM-1107 |  | 462382 | |
| 10513-1 | Nelfinavir | Viracept |  | 64143 | |
| 10099-2 | Nilotinib | AMN-107 | LSM-1099 |  | 644241 |
| 10266-1 | NSC 663284 | LSM-2042 |  | 379077 | |
| 10267-1 | NU6102 | LSM-4287 |  | 4566 | |
| 10268-1 | Nutlin 3a | LSM-6351 |  | 11433190 | |
| 10344-1 | Olomoucine II | LSM-6356 |  | 10067756 | |
| 10146-2 | Omipalisib | GSK2126458; GSK2126458A | LSM-1147 |  | 25167777 |
| 10269-1 | Oxaliplatin | Eloxatin | LSM-44941 |  | 5310940 |
| 10270-1 | Oxamflatin | LSM-4290 |  | 4611 | |
| 10026-3 | PD173074 | LSM-1026 |  | 1401 | |
| 10048-6 | PD184352 | CI-1040 | LSM-1048 |  | 6918454 |
| 10048-7 | PD184352 | CI-1040 | LSM-1048 |  | 6918454 |
| 10048 | PD184352 | CI-1040 | LSM-1048 | | 6918454 |
| 10271-2 | PD 98059 | LSM-3394 |  | 4713 | |
| 10272-1 | Pemetrexed | Alimta | LSM-6353 |  | 446556 |
| 10265-1 | Pevonedistat | MLN 4924; MLN-4924; MLN4924 | LSM-6263 |  | 16720766 |
| 10514-1 | PS-1145 |  | 9949093 | ||
| 10273-1 | Purvalanol A | LSM-3118 |  | 456214 | |
| 10516-1 | Ribavirin | Tribavirin |  | 37542 | |
| 10274-1 | SB-3CT | LSM-4293 |  | 9883002 | |
| 10056-2 | Selumetinib | AZD6244; Array142886 | LSM-1056 |  | 10127622 |
| 10035-2 | Sigma A6730 | KIN001-102; AKT inhibitor VIII; Akt1/2 kinase inhibitor | LSM-1035 |  | 10196499 |
| 10052-3 | Sirolimus | Rapamycin | LSM-1052 |  | 5040 |